Occupational Therapists in Suwanee, GA Accepting Medicare
65 Occupational Therapists found. Showing 61 - 65
 Deanna Nicole Zecchino, MSOT,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5000 Research Ct Ste 450, Suwanee, GA 30024 Phone: 770-205-5551 |
 Samuel Abraham, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 6735 Hempstead Ct, Suwanee, GA 30024 Phone: 870-329-4117 |
Makensie Thompson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3905 Johns Creek Ct, Suite 250, Suwanee, GA 30024 Phone: 770-888-5221 Fax: 678-680-5929 |
Verna Elaine Campos, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5000 Research Ct Ste 450, Suwanee, GA 30024 Phone: 706-615-7467 |
Emalyn Brumby, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4055 Johns Creek Pkwy, Suwanee, GA 30024 Phone: 770-888-5221 |
News Archive
Study offers new possibilities for breast and other cancer therapies
Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals.
Grants flow from Komen to Planned Parenthood
Grants from the Susan G. Komen Foundation for the Cure are flowing to Planned Parenthood, as the women's health organizations seek to rebuild their relationship after the controversy in February over the breast cancer charity's unsuccessful attempt to defund Planned Parenthood.
Mice may hold the key to longer life
Scientists from the University of Aberdeen, the Aberdeen-based Rowett Research Institute and the Medical Research Council (MRC) in Cambridge have made a major breakthrough in understanding how metabolism affects lifespan.
Gilead to boost price of new hepatitis c drug
Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.
Key COVID-19 information for gastroenterologists and patients with digestive conditions
A paper published today in Clinical Gastroenterology and Hepatology by clinicians at Icahn School of Medicine at Mount Sinai outlines key information gastroenterologists and patients with chronic digestive conditions need to know about COVID-19, or coronavirus.
› Verified 4 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Optometrists
Podiatrists
Audiologists